SG10201408166QA - Probiotic microorganisms as active agents for enhancing the radiance of the skin’s complexion - Google Patents

Probiotic microorganisms as active agents for enhancing the radiance of the skin’s complexion

Info

Publication number
SG10201408166QA
SG10201408166QA SG10201408166QA SG10201408166QA SG10201408166QA SG 10201408166Q A SG10201408166Q A SG 10201408166QA SG 10201408166Q A SG10201408166Q A SG 10201408166QA SG 10201408166Q A SG10201408166Q A SG 10201408166QA SG 10201408166Q A SG10201408166Q A SG 10201408166QA
Authority
SG
Singapore
Prior art keywords
complexion
radiance
enhancing
skin
active agents
Prior art date
Application number
SG10201408166QA
Other languages
English (en)
Inventor
Audrey Gueniche
Isabelle Castiel
Original Assignee
Oreal
Nestec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal, Nestec filed Critical Oreal
Publication of SG10201408166QA publication Critical patent/SG10201408166QA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG10201408166QA 2009-12-08 2010-12-07 Probiotic microorganisms as active agents for enhancing the radiance of the skin’s complexion SG10201408166QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0958750A FR2953408B1 (fr) 2009-12-08 2009-12-08 Microorganismes probiotiques a titre d'actif pour l'eclat du teint de la peau
US28220809P 2009-12-30 2009-12-30

Publications (1)

Publication Number Publication Date
SG10201408166QA true SG10201408166QA (en) 2015-02-27

Family

ID=42557464

Family Applications (2)

Application Number Title Priority Date Filing Date
SG2012041174A SG181512A1 (en) 2009-12-08 2010-12-07 Probiotic microorganisms as active agents for enhancing the radiance of the skin's complexion
SG10201408166QA SG10201408166QA (en) 2009-12-08 2010-12-07 Probiotic microorganisms as active agents for enhancing the radiance of the skin’s complexion

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG2012041174A SG181512A1 (en) 2009-12-08 2010-12-07 Probiotic microorganisms as active agents for enhancing the radiance of the skin's complexion

Country Status (12)

Country Link
US (1) US20120301452A1 (zh)
EP (2) EP2509580A1 (zh)
JP (1) JP2013512946A (zh)
KR (1) KR20120133373A (zh)
CN (3) CN107595762A (zh)
BR (1) BR112012013722A2 (zh)
ES (1) ES2639023T3 (zh)
FR (1) FR2953408B1 (zh)
MX (1) MX348797B (zh)
PT (1) PT2332520T (zh)
SG (2) SG181512A1 (zh)
WO (1) WO2011070508A1 (zh)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005291098B2 (en) * 2004-10-04 2011-11-24 L'oreal Cosmetic and/or dermatological composition for sensitive skins
FR2889057B1 (fr) * 2005-08-01 2008-07-18 Oreal Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
FR2920305B1 (fr) * 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
FR2920304B1 (fr) 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
FR2953407B1 (fr) * 2009-12-08 2013-06-14 Oreal Microorganismes probiotiques a titre d'actif contre les alterations du microrelief
CN102078486B (zh) * 2011-01-21 2012-06-20 吉林紫鑫药物研究有限公司 一种祛黄褐斑的药物组合物及其制备方法
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US10940169B2 (en) 2015-11-30 2021-03-09 Joseph E. Kovarik Method for reducing the likelihood of developing cancer in an individual human being
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
FR2973226B1 (fr) 2011-04-01 2013-03-29 Oreal Utilisation de composes (ethoxy-hydroxyphenyl)alkylcetone ou ethoxyhydroxyalkylphenol pour traiter la peau grasse
CA2863681A1 (en) 2012-02-14 2013-08-22 The Procter & Gamble Company Topical use of a skin-commensal prebiotic agent and compositions containing the same
GB201206599D0 (en) * 2012-04-13 2012-05-30 Univ Manchester Probiotic bacteria
KR20150065170A (ko) 2012-08-07 2015-06-12 탑제닉스, 인크. 관심있는 화합물을 발현하는 형질전환된 박테리아를 포함하는 국소 조성물
KR101998210B1 (ko) * 2012-10-31 2019-07-10 (주)아모레퍼시픽 녹차 유산균을 포함하는 피부 각질 제거용 조성물
FR2999930A1 (fr) * 2012-12-21 2014-06-27 Oreal Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
FR2999931A1 (fr) * 2012-12-21 2014-06-27 Oreal Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
US10413577B2 (en) * 2013-02-22 2019-09-17 The Regents Of The University Of California Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong life
FR3004349B1 (fr) * 2013-04-15 2015-11-27 Greentech Applications cosmetiques et pharmaceutiques de lactobacillus pentosus
CN103238851A (zh) * 2013-05-15 2013-08-14 百岳特生物科技（上海）有限公司 用于减重的含胶原蛋白的食品组成物
US11642382B2 (en) 2013-12-20 2023-05-09 Seed Health, Inc. Method for treating an individual suffering from bladder cancer
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11213552B2 (en) 2015-11-30 2022-01-04 Joseph E. Kovarik Method for treating an individual suffering from a chronic infectious disease and cancer
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11529379B2 (en) 2013-12-20 2022-12-20 Seed Health, Inc. Method and system for reducing the likelihood of developing colorectal cancer in an individual human being
US11672835B2 (en) 2013-12-20 2023-06-13 Seed Health, Inc. Method for treating individuals having cancer and who are receiving cancer immunotherapy
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11026982B2 (en) 2015-11-30 2021-06-08 Joseph E. Kovarik Method for reducing the likelihood of developing bladder or colorectal cancer in an individual human being
US10584344B2 (en) 2014-06-17 2020-03-10 Crown Laboratories, Inc. Genetically modified bacteria and methods for genetic modification of bacteria
KR20170019427A (ko) 2014-06-17 2017-02-21 탑제닉스, 인크. Ｕｖ 차단을 위한 국소용 제형
KR101645531B1 (ko) * 2014-10-23 2016-08-04 주식회사 엘지생활건강 게니스테인 및 다이드제인을 함유하는 액정젤 및 이를 포함하는 항노화용 화장료 조성물
WO2016090252A1 (en) 2014-12-04 2016-06-09 Mary Kay Inc. Topical skin care composition comprising trifluoroacetyl tripeptide-2
WO2016130983A1 (en) * 2015-02-12 2016-08-18 Fine Kenneth Davin Probiotic deodorant
US11504404B2 (en) 2016-02-24 2022-11-22 Crown Laboratories, Inc. Skin probiotic formulation
EP3436041B1 (en) 2016-03-31 2023-05-24 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
JP2019510037A (ja) 2016-03-31 2019-04-11 ゴジョ・インダストリーズ・インコーポレイテッド 抗菌ペプチド刺激性洗浄組成物
EP3544575A1 (en) 2016-11-23 2019-10-02 GOJO Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
KR101783728B1 (ko) * 2016-11-30 2017-10-10 바이오앤슈티 주식회사 발효 커피 원두를 유효성분으로 포함하는 피부 미백용 조성물
US11229806B2 (en) * 2017-05-08 2022-01-25 L'oreal Cold atmospheric plasma treatment with chemical or organic compounds to modify the keratinous substrate microbiota
CN107184732A (zh) * 2017-07-15 2017-09-22 盖文卓 一种用于祛黄褐斑的药物组合物及其制备方法
US20190060216A1 (en) * 2017-08-31 2019-02-28 Muhammed Majeed Anti-pollution compositions containing bacillus coagulans
CN108125902A (zh) * 2018-01-08 2018-06-08 北京科拓恒通生物技术股份有限公司 一种益生菌组合物、护肤精华液和面膜及其制备方法
TWI731209B (zh) * 2018-01-09 2021-06-21 柯順議 益生菌組合物及其用途
IT201800003428A1 (it) * 2018-03-12 2019-09-12 Fb Dermo S R L Composizione cosmetica per il trattamento di alterazioni della iperpigmentazione della pelle
KR102140139B1 (ko) * 2018-03-22 2020-07-31 주식회사 세바바이오텍 피부 유래 유산균 및 그 배양물을 포함하는 화장료 조성물
CN109601982A (zh) * 2018-12-14 2019-04-12 华南理工大学 一种具有祛除黄褐斑功能的保健食品及其制备方法与应用
FR3090384B1 (fr) * 2018-12-21 2021-05-28 Lvmh Rech Effet pro-vitaminique d’un extrait d’un microorganisme probiotique
FR3090383B1 (fr) * 2018-12-21 2021-05-28 Lvmh Rech Composition comprenant un extrait de Lactobacillus rhamnosus
KR102123022B1 (ko) * 2018-12-31 2020-06-16 코스맥스 주식회사 피부에 효능이 있는 고농도 프로바이오틱스를 포함하는 조성물
US11672742B2 (en) * 2019-01-03 2023-06-13 Surface Deep LLC Deodorant including at least one fruit acid and methods of using the same
CN109907262A (zh) * 2019-03-28 2019-06-21 广东时代食品与生命健康研究有限公司 一种益生菌组合物
CN109864965A (zh) * 2019-03-28 2019-06-11 叶绿芝生物科技（中山）有限公司 一种黄金肌底液组合物
CN109938230A (zh) * 2019-05-07 2019-06-28 江苏华桑食品科技有限公司 一种具有美白功能的饮料的制备方法
CN112245382A (zh) * 2019-07-03 2021-01-22 广东巴松那生物科技有限公司 一种光滑皮肤的磨砂精华液及其制备方法
FR3105922B1 (fr) * 2020-01-08 2022-12-02 Le Rouge Francais Composition cosmétique pour le traitement des lèvres sous forme de solide compact contenant au moins un agent probiotique et au moins un composé choisi parmi l'acide hyaluronique et ses dérivés.
CN112716850B (zh) * 2021-01-15 2023-07-18 曾万祥 一种具有调节皮肤微生态平衡的组合物及其应用
KR20230140872A (ko) * 2022-03-30 2023-10-10 주식회사 락토메이슨 페디오코쿠스 아시디락티시 lm1013을 유효성분으로 포함하는 자외선에 의한 피부 손상 예방 또는 개선용 조성물
EP4368192A1 (en) 2022-11-09 2024-05-15 Cépages Combination of a lactobacillus strain and a grape extract for use as an anti-ageing agent

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3024318A1 (de) 1980-06-27 1982-01-28 Chemisches Laboratorium Dr. Karl Richter GmbH, 1000 Berlin Kosmetische mittel
FR2718752B1 (fr) * 1994-04-15 1996-07-12 World Trust Investment Sa Préparations à base de lactosérum fermenté et leurs utilisations.
CN1136429A (zh) * 1995-01-24 1996-11-27 康白 微生态制剂美容霜及其制备方法
NL1010770C2 (nl) * 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
CA2424607C (en) * 2000-10-06 2013-01-15 Societe Des Produits Nestle S.A. Use of probiotic lactic acid bacteria for balancing the skin's immune system
US20050069505A1 (en) * 2002-02-21 2005-03-31 Lionel Breton Orally administrable composition for the photoprotection of the skin
EP1572145A1 (en) * 2002-12-13 2005-09-14 L'oreal Use of an extract of decaffeinated coffee beans in the preparation of a composition intended to stimulate the sebaceous function of the skin by oral administration
FR2872047B1 (fr) * 2004-06-23 2007-06-15 Oreal Composition pour peaux sensibles associant cation mineral et probiotique(s)
JP2008503563A (ja) * 2004-06-23 2008-02-07 ロレアル 敏感及び／又は乾燥肌の予防及び／又は処置に有用な方法及び組成物
AU2005291098B2 (en) * 2004-10-04 2011-11-24 L'oreal Cosmetic and/or dermatological composition for sensitive skins
FR2876029B1 (fr) * 2004-10-04 2008-11-14 Oreal Composition cosmetique et/ou dermatologique pour peaux sensibles.
US20060269508A1 (en) * 2005-03-29 2006-11-30 Trejo Amy V Means for regulating the cosmetic appearance and/or health of human keratinous tissue
EP2308566B1 (en) * 2005-04-08 2017-07-05 The Procter and Gamble Company Use of orally administered probiotic bifidobacteria for human beauty benefits
FR2889057B1 (fr) * 2005-08-01 2008-07-18 Oreal Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
JP5121715B2 (ja) * 2006-08-10 2013-01-16 ハウスウェルネスフーズ株式会社 保湿剤
CA2697735C (en) * 2007-09-04 2014-02-18 L'oreal Use of a combination of hesperidin and of a microorganism for influencing the barrier function of the skin
FR2938437B1 (fr) * 2008-11-19 2020-03-27 Société des Produits Nestlé S.A. Utilisation cosmetique de microorganisme pour le traitement des peaux grasses

Also Published As

Publication number Publication date
FR2953408A1 (fr) 2011-06-10
EP2332520A1 (fr) 2011-06-15
PT2332520T (pt) 2017-09-12
CN107595762A (zh) 2018-01-19
CN104188888A (zh) 2014-12-10
WO2011070508A1 (en) 2011-06-16
US20120301452A1 (en) 2012-11-29
SG181512A1 (en) 2012-07-30
EP2509580A1 (en) 2012-10-17
CN102791253A (zh) 2012-11-21
BR112012013722A2 (pt) 2017-04-04
KR20120133373A (ko) 2012-12-10
JP2013512946A (ja) 2013-04-18
MX2012006628A (es) 2012-07-10
ES2639023T3 (es) 2017-10-25
MX348797B (es) 2017-06-29
FR2953408B1 (fr) 2013-02-08
EP2332520B1 (fr) 2017-06-14

Similar Documents

Publication Publication Date Title
SG10201408166QA (en) Probiotic microorganisms as active agents for enhancing the radiance of the skin’s complexion
EP2391344A4 (en) COMPOSITIONS FOR THE TREATMENT OF NAILS AND SKIN
HK1178074A1 (zh) 用於腫瘤診斷和治療的組合物和方法
EP2654745A4 (en) COMPOSITION FOR TREATING SKIN CONDITIONS OF THE SKIN
ZA201208413B (en) Skin treatment composition
HK1223274A1 (zh) 用於治療淺表病變的組合物
IL240560A0 (en) Preparations and methods for tumor diagnosis and treatment
PL2575971T3 (pl) Połączone wyciągi roślinne do zastosowania w leczeniu zakażeń drobnoustrojami
PL2276498T3 (pl) Zastosowanie bakterii probiotycznych do leczenia hiperhomocysteinemii
IL214133A0 (en) Skin treatment
GB2455585B (en) Capsicum seeds for the treatment of eczema and dermatitis
IL206577A0 (en) Formulations of flibanserin
EP2361317A4 (en) USE OF EIF3M FOR THE DIAGNOSIS AND TREATMENT OF CANCER
EP2488507A4 (en) NOVEL MEK INHIBITORS USEFUL IN THE TREATMENT OF DISEASES
ZA201208568B (en) Skin treatment composition
HK1214771A1 (zh) 用於治療皮膚病的製劑
IL202506A0 (en) Neramexane for the treatment of nystagmus
SI2531124T1 (sl) Naprava za zdravljenje kožnih lezij
ZA201005770B (en) The treatment of damaged skin
IL222642A0 (en) Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males
PT2456445E (pt) Agente para o tratamento de condições da pele
IL219444A (en) Procine for use in the treatment of blood cell infections
GB2473735B (en) Skin treatment formulation
AU2009904943A0 (en) Skin Treatment Formulation
AU2010904905A0 (en) Methods and compositions for maintaining and improving the health of skin